Carcinogenesis studies with iron oxides.
Seven different types of iron oxide were examined for carcinogenic properties in intratracheal instillation and intraperitoneal injection tests on rats, which represent particularly sensitive methods for local carcinogenic effects. The total doses lay in the range of maximum tolerance (390/1,530 mg/kg i.t. or 600 mg/kg i.p.). With one exception, at least 50 male and 50 female Sprague-Dawley rats were used per test group, control group and route of administration. Two iron oxides were additionally instilled intratracheally in combination with benzo[a]pyrene. No carcinogenic effect could be demonstrated for the test iron oxides RBW 07105/SV2 (fibrous, magnetic, surface doped with 1.85% cobalt), development product Bayferrox AC 5100 M (fibrous, magnetic, bulk doped with 2.1% cobalt), Bayferrox 1352 (fibrous alpha-Fe2O3), Bayferrox 920 (fibrous alpha-FeOOH), Bayferrox 130 (cubic alpha-Fe2O3), Bayferrox 306 (cubic Fe3O4), or Brazilian iron ore AC 5031 N (alpha-Fe2O3).
Steinhoff
D
D
BAYER AG, Institute of Toxicology, Wuppertal, Germany.
Mohr
U
U
Hahnemann
S
S
D000818:Animals; D015197:Carcinogenicity Tests; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000633:toxicity*; D008175:Lung Neoplasms / Q000139:chemically induced*; D051381:Rats; D011919:Rats, Inbred Strains
D005296:Ferrous Compounds